Adaptive Biotechnologies President Rubinstein Sells $802K in ADPT Stock

AI Summary

Adaptive Biotechnologies' president, Rubinstein, sold $802,000 worth of ADPT stock. This sale raises questions about the company's leadership and investor confidence. Insider sales can influence market perception and stock performance. The transaction may impact investor sentiment regarding ADPT's future stock value.